Published in J Steroid Biochem on January 01, 1980
Assessment of estrogen receptor--histone interactions. Proc Natl Acad Sci U S A (1981) 0.77
A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell (1980) 2.28
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21
ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology (2001) 2.18
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res (1982) 2.15
Inhibition of breast cancer growth by suramin. J Natl Cancer Inst (1992) 2.10
Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol (1999) 2.09
Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica (1979) 2.07
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84
Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet (1989) 1.77
Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun (1979) 1.76
Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol (1994) 1.52
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes (2001) 1.50
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology (1986) 1.50
Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci U S A (1992) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene (1990) 1.47
[Attempted separation of 2 mitochondrial membranes]. C R Acad Sci Hebd Seances Acad Sci D (1966) 1.41
Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction. Am J Dermatopathol (1999) 1.40
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res (1998) 1.37
Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem (1987) 1.36
Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene (1995) 1.35
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res (1989) 1.34
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res (1987) 1.33
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis (1997) 1.32
Xenopus laevis serum albumins are encoded in two closely related genes. Nucleic Acids Res (1981) 1.32
Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol (1999) 1.32
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem (1984) 1.31
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res (1988) 1.30
Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun (1987) 1.29
Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations. Eur J Clin Microbiol Infect Dis (2009) 1.23
Nail biology and nail science. Int J Cosmet Sci (2007) 1.22
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab (1982) 1.20
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem (1981) 1.20
Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology (1980) 1.20
A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene (2001) 1.19
The human genome contains multiple sequences of varying homology to mouse mammary tumour virus DNA. Gene (1984) 1.19
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer (1998) 1.18
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol (1998) 1.17
Expression of human sequences related to those of mouse mammary tumor virus. J Virol (1988) 1.16
Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol (1988) 1.15
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res (1988) 1.15
Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia (2002) 1.14
[Separation of the mitochondrial membranes. Purification and enzymatic characterization of the outer membrane]. Biochim Biophys Acta (1967) 1.14
Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol (1994) 1.14
Vitellogenin B2 gene in Xenopus laevis: isolation, in vitro transcription and relation to other vitellogenin genes. Nucleic Acids Res (1983) 1.13
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol (1987) 1.13
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun (1986) 1.12
A prolonged outbreak of Shigella sonnei infections in traditionally observant Jewish communities in North America caused by a molecularly distinct bacterial subtype. J Infect Dis (1998) 1.11
Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem (1997) 1.11
Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res (1990) 1.10
Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem (1993) 1.10
Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci U S A (1996) 1.10
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol (1995) 1.09
Unusual T cell pseudolymphoma with features of so-called pseudolymphomatous folliculitis. Dermatology (2002) 1.09
Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J Clin Invest (1989) 1.08
Isolation and characterization of ribosomes from yeast mitochondria. FEBS Lett (1969) 1.08
An estrogen receptor from Xenopus laevis liver possibly connected with vitellogenin synthesis. Cell (1978) 1.08
Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res (1982) 1.08
Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis (1995) 1.08
[Purification and enzymatic characterization of the external membrane of mitochondria]. C R Acad Sci Hebd Seances Acad Sci D (1966) 1.07
Mitoribosomes from Candida utilis. Morphological, physical, and chemical characterization of the monomer form and of its subunits. J Cell Biol (1972) 1.07
Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci (1994) 1.07
Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J (2001) 1.06
Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer (1998) 1.06
Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol (2000) 1.05
Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. J Endocrinol (2003) 1.05
Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol (1989) 1.05
Enzyme sensitisation in consumers of enzyme-containing washing powder. Lancet (1970) 1.04
Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer (1993) 1.02
Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells (1996) 1.02
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol (1980) 1.02
Estrogen causes a rapid, large and prolonged rise in the level of nuclear estrogen receptor in Xenopus laevis liver. Biochem Biophys Res Commun (1979) 1.01
Assessment of specificity of oestrogen receptor-DNA interaction by a competitive assay. Nature (1978) 1.00
Steroid hormone receptors. Vitam Horm (1975) 1.00
The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur J Cancer (1996) 0.99
Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99
Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ (1995) 0.99
Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer (1997) 0.99
Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem (1987) 0.98
Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine. Biochem Biophys Res Commun (1972) 0.98
Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A (1993) 0.98
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. J Biol Chem (1984) 0.98
Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone action. Recent Prog Horm Res (1971) 0.97
Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line. J Steroid Biochem Mol Biol (2000) 0.96
In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor. Mol Cell Endocrinol (1975) 0.96
Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. Cancer Res (1985) 0.96
Differences between oestrogen receptor activation by oestrogen and antioestrogen. Nature (1981) 0.96